All Categories APDN in the News Corporate/Financial News Investors Large-Scale DNA Production Linear DNA Press Release Uncategorized Vaccines

Category: Press Release

Applied DNA Sciences Set to Join Russell Microcap Index

June 26th, 2020

Applied DNA Secures Grant from National Grid Partnered with the New York State MEP to Support Manufacture of COVID-19 Diagnostic Kits and Vaccine Candidates

June 9th, 2020

APDN Provides Update on Linear-DNA COVID-19 Vaccine Candidates

June 8th, 2020

Applied DNA to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27

May 21st, 2020

Applied DNA Reports 2020 Fiscal Second Quarter Financial Results

May 14th, 2020

Applied DNA Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit

May 14th, 2020

Applied DNA Schedules Fiscal 2020 Second Quarter Financial Results Conference Call for Thursday, May 14, 2020 at 4:30 PM ET

May 7th, 2020

Applied DNA Receives Approximately $5.3 Million in Net Proceeds from Warrant Exercise

May 6th, 2020

Applied DNA Applies to U.S. FDA for Emergency Use Authorization for COVID-19 Diagnostic Kit

May 5th, 2020